The diagnostic value of biomarkers in allergic and non-allergic asthma phenotype Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics Year: 2018
A comparative analysis of the non-specific bronchial hyperreactivity in patients with newly discovered bronchial asthma combined with allergic rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 235s Year: 2006
Galectn-3 : marker of airway inflammation in bronchial asthma Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018
Is bronchial hyperresponsiveness(BHR) a diagnostic feature of asthma? Source: Eur Respir J 2001; 18: Suppl. 33, 454s Year: 2001
Bronchial hyperreactivity in asthma: relationship with clinical severity and therapy Source: Eur Respir J 2005; 26: Suppl. 49, 617s Year: 2005
Allergic inflammation markers for earlier diagnosis of bronchial asthma in patients with allergic rhinitis Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008
eNose breathprints as surrogate biomarkers for classifying asthma patients by atopy Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019
Cysteinyl-leukotriene levels in sputum differentiate asthma from rhinitis patients with or without bronchial hyperresponsiveness Source: Annual Congress 2007 - Asthma subphenotypes Year: 2007
Clinical features and their link with asthma exacerbations amongst aspirin-induced asthmatics Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010
Is DawNO a new measurement to characterise allergic and non-allergic asthma? Source: Annual Congress 2009 - One size (does not) fit all: phenotyping and controlling asthma Year: 2009
Atopy, lung function and bronchial responsiveness in former paediatric asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 450s Year: 2005
Cough variant asthma may be a incipience of bronchial asthma Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012
Is atopy an important factor of bronchial hyperresponsiveness in asthmatic patients? Source: Eur Respir J 2001; 18: Suppl. 33, 368s Year: 2001
Diagnostic value of specific nasal provocation in the diagnosis of allergic rhinitis in mild persistent asthma cases Source: Eur Respir J 2002; 20: Suppl. 38, 218s Year: 2002
Definitions and types of work-related asthma: a nosological approach Source: Eur Respir J 2003; 21: 706-712 Year: 2003
Neuroregulatorial therapy of bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 55s Year: 2002
Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001
How much do varying definitions of atopy and airway hyperresponsivenss affect asthma phenotype Source: Eur Respir J 2001; 18: Suppl. 33, 287s Year: 2001
Relationship between bronchial hyperresponsiveness and response to β2 -agonists in steroid-naïve patients with mild asthma Source: Eur Respir J 2002; 20: Suppl. 38, 503s Year: 2002
The prevalence and severity of bronchial hyperresponsiveness (BHR) in asthmatic children in general practice Source: Eur Respir J 2002; 20: Suppl. 38, 79s Year: 2002